🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a 60-to-72 week multicenter study to evaluate Infergen and Ribaviri...
Status
Terminated
Location
Atlantic Gastroenterology Associates
Start Date
2007-02
Trial ID
NCT00456248
Treatments Being Tested
Efficacy and safety is compared between interferon alfacon-1 alone and conc...
Status
Completed
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00239252
Treatments Being Tested
This study is to confirm the potential effects and assess the safety of a n...
Status
Completed
Location
First Affiliated Hospital of Lanzhou University
Start Date
2013-06
Trial ID
NCT01903278
Treatments Being Tested
This Phase 3 clinical study is designed to evaluate the safety, tolerabilit...
Status
Completed
Location
Multiple Locations
Start Date
2005-02
Trial ID
NCT00162734
Genotype 1 hepatitis C virus (HCV) patients who did not respond (did not lo...
Status
Completed
Location
Brooke Army Medical Center
Start Date
2005-10
Trial ID
NCT00207402
Treatments Being Tested
This dose-escalating study is to evaluate the efficacy and the safety of di...
Status
Completed
Location
The First Affiliated Hospital of Fujian Medical University
Start Date
2012-10
Trial ID
NCT01908335
Treatments Being Tested
Data have suggested that consensus interferon (CIFN) has greater antiviral ...
Status
Completed
Location
Multiple Locations
Start Date
2005-07
Trial ID
NCT00211692
The main purpose of this study is to evaluate the safety and tolerability o...
Status
Completed
Location
Beth Israel Medical Center
Start Date
2005-12
Trial ID
NCT00266318
Treatments Being Tested
This observational prospective registry is designed to evaluate the safety,...
Status
Withdrawn
Location
Multiple Locations
Start Date
2009-08
Trial ID
NCT00951223
Treatments Being Tested
To evaluate the safety and tolerability of two different doses of Consensus...
Status
Completed
Location
InterMune, Inc.
Start Date
2004-04
Trial ID
NCT00084279
Treatments Being Tested